Healthcare provider profile · identity verified

Scott E Dickman, MD

Family Practice · WISCONSIN RAPIDS, WI · NPI 1588676977

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	499	162
Rosuvastatin Calcium	Rosuvastatin Calcium	467	136
Omeprazole	Omeprazole	413	119
Metoprolol Succinate	Metoprolol Succinate	301	84
Lisinopril	Lisinopril	292	89
Amlodipine Besylate	Amlodipine Besylate	285	100
Losartan Potassium	Losartan Potassium	282	92
Metformin Hcl	Metformin Hcl	278	92
Levothyroxine Sodium	Levothyroxine Sodium	273	83
Hydrochlorothiazide	Hydrochlorothiazide	236	79
Tamsulosin Hcl	Tamsulosin Hcl	208	61
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	203	62
Metoprolol Tartrate	Metoprolol Tartrate	168	54
Warfarin Sodium	Warfarin Sodium	167	37
Simvastatin	Simvastatin	166	59
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	164	163
Gabapentin	Gabapentin	135	42
Allopurinol	Allopurinol	121	41
Furosemide	Furosemide	119	40
Eliquis	Apixaban	113	27
Alendronate Sodium	Alendronate Sodium	107	35
Glimepiride	Glimepiride	103	36
Pantoprazole Sodium	Pantoprazole Sodium	102	30
Famotidine	Famotidine	98	28
Lovastatin	Lovastatin	96	25
Clopidogrel	Clopidogrel Bisulfate	93	29
Potassium Chloride	Potassium Chloride	93	29
Montelukast Sodium	Montelukast Sodium	88	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	87	28
Trazodone Hcl	Trazodone Hcl	84	27
Albuterol Sulfate Hfa	Albuterol Sulfate	81	26
Citalopram Hbr	Citalopram Hydrobromide	77	24
Finasteride	Finasteride	75	18
Jardiance	Empagliflozin	73	18
Hydralazine Hcl	Hydralazine Hcl	71	20
Pravastatin Sodium	Pravastatin Sodium	68	26
Hydroxyzine Hcl	Hydroxyzine Hcl	62	21
Carvedilol	Carvedilol	61	19
Spironolactone	Spironolactone	61	18
Quetiapine Fumarate	Quetiapine Fumarate	59	17
Escitalopram Oxalate	Escitalopram Oxalate	55	14
Sertraline Hcl	Sertraline Hcl	55	22
Atenolol	Atenolol	52	16
Diclofenac Sodium	Diclofenac Sodium	51	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	18
Metformin Hcl Er	Metformin Hcl	48	19
Amitriptyline Hcl	Amitriptyline Hcl	46	18
Donepezil Hcl	Donepezil Hcl	45	suppressed
Fluticasone Propionate	Fluticasone Propionate	45	22
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	42	12
Ezetimibe	Ezetimibe	41	12
Paroxetine Hcl	Paroxetine Hcl	41	12
Mirtazapine	Mirtazapine	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	13
Chlorthalidone	Chlorthalidone	35	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	34	suppressed
Ozempic	Semaglutide	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Meloxicam	Meloxicam	32	suppressed
Bumetanide	Bumetanide	31	12
Glipizide Er	Glipizide	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	12
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Prednisone	Prednisone	28	21
Trulicity	Dulaglutide	28	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Glipizide	Glipizide	26	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Raloxifene Hcl	Raloxifene Hcl	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Klor-Con M20	Potassium Chloride	24	suppressed
Nystatin	Nystatin	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Repatha Sureclick	Evolocumab	20	suppressed
Azithromycin	Azithromycin	19	17
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Gemfibrozil	Gemfibrozil	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Nexium	Esomeprazole Magnesium	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	12
Fosinopril Sodium	Fosinopril Sodium	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Baclofen	Baclofen	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Colchicine	Colchicine	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Levofloxacin	Levofloxacin	14	13
Lorazepam	Lorazepam	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Primidone	Primidone	12	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Topiramate	Topiramate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error